Cargando…
Increased Cerebrospinal Fluid S100B and NSE Reflect Neuronal and Glial Damage in Parkinson’s Disease
Introduction: The diagnosis of Parkinson’s disease (PD) mainly relies on clinical manifestation, but may be difficult to make in very early stages of the disease, especially in pre-motor PD. Thus, there is great interest in finding a biomarker for PD. Among diagnostic biomarkers, the most promising...
Autores principales: | Papuć, Ewa, Rejdak, Konrad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387568/ https://www.ncbi.nlm.nih.gov/pubmed/32792937 http://dx.doi.org/10.3389/fnagi.2020.00156 |
Ejemplares similares
-
Increased CSF NFL in Non-demented Parkinson’s Disease Subjects Reflects Early White Matter Damage
por: Papuć, Ewa, et al.
Publicado: (2020) -
Biomarkers of Brain Damage: S100B and NSE Concentrations in Cerebrospinal Fluid—A Normative Study
por: Hajduková, Lenka, et al.
Publicado: (2015) -
Increased Serum NSE and S100B Indicate Neuronal and Glial Alterations in Subjects Under 71 Years With Mild Neurocognitive Disorder/Mild Cognitive Impairment
por: Polyakova, Maryna, et al.
Publicado: (2022) -
Decreased Cerebrospinal Fluid Orexin-A (Hypocretin-1) Concentrations in Patients after Generalized Convulsive Status Epilepticus
por: Samzadeh, Mojdeh, et al.
Publicado: (2020) -
The role of myelin damage in Alzheimer’s disease pathology
por: Papuć, Ewa, et al.
Publicado: (2018)